Allergy Immunotherapies Market to Reach US$ 7.71 Billion by 2034 at 7.92% CAGR
The Allergy Immunotherapies Market is experiencing strong growth as healthcare providers increasingly adopt disease-modifying treatments that address the root causes of allergic disorders rather than merely controlling symptoms. Allergy immunotherapies involve the gradual administration of specific allergens to desensitize the immune system and reduce reactions to triggers such as pollen, dust...
0 Comments 0 Shares 4 Views 0 Reviews